PARP1 and neuroblastoma: In neuroblastoma, butein treatment resulted in a significant ROS increase and cell cycle arrest, regulated the Bcl-2/Bax ratio, stimulated caspase and PARP activity, decreased cell viability, and induced apoptosis[53].